Drug discovery is a team sport at Vertex Pharmaceuticals. In recognition of British Science Week, hear from Site Head David Price and scientists in Oxford, U.K., about the power of connections in science.

Vertex is committed to the sickle cell disease community. Beyond our science, it’s about showing up and locking arms with the community to work together toward meaningful change.

Learn about one of our innovative approaches, cell encapsulation. This is just one of the tools in our drug discovery toolbox that has the potential to treat serious diseases.

Vice President of Clinical Development Dr. Ogo Egbuna shares why it’s important to raise awareness about APOL1-mediated kidney disease (AMKD). 

Learn why the Vertex Pharmaceuticals approach to career growth is unique from Chief Human Resources Officer Stephanie Franklin.

Learn more about cystic fibrosis and how we are committed now more than ever to discovering new therapeutic advances for all people living with the disease.

Looking back on 2022, the Vertex Foundation remains grateful and excited for the future. From supporting healthy families to social innovation and STEAM education, we’re proud of the impact Foundation partners continue to make in our communities around the world. 

Mark Higgins, Senior Director of Clinical Development, highlights Vertex’s patient-first approach to clinical trials and discusses his experience discovering potential treatments for people with cystic fibrosis.

Unique summer camp experiences dedicated to the siblings of children with a serious illness? Sign us up! Having a child with a serious illness impacts the whole family, and sibling camp is just one way the Vertex Foundation supports healthy families across the globe. 

ID&E Week is our annual opportunity to press pause and listen, learn and reflect. This year’s theme, “Catalysts for Change,” was also a call to action for Vertexians to ignite actionable change. Hear from Vice President Diana Cruz Solash on key takeaways from our sixth annual ID&E Week.